Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Brain Behav Immun. 2016 May 26;59:55–61. doi: 10.1016/j.bbi.2016.05.019

Figure 2.

Figure 2

Mean percentage of donor cell engraftment from splenoctyes. (A) Percentage of CD45.1+ (BTBR origin) CD3+ T-cells and (B) CD45.2 (C57 origin) CD3+ T-cells. (C) Percentage of CD45.1+ CD11b+ myeloid cells and (D) CD45.2+ CD11b+ cells. Significant differences in the presence of both CD45 alleles were detected between allogeneic and syngeneic recipients in spleen tissue of both strains. *p < 0.05. C57-Syngeneic n = 6, C57-Allogeneic n = 6, BTBR-Syngeneic n = 6, BTBR-Allogeneic, n = 6.